Chemoinformaics analysis of (S)-1,7-Bis(4-hydroxyphenyl)-5-hydroxyheptan-3-one
| Molecular Weight | 314.381 | nRot | 8 |
| Heavy Atom Molecular Weight | 292.205 | nRig | 13 |
| Exact Molecular Weight | 314.152 | nRing | 2 |
| Solubility: LogS | -2.503 | nHRing | 0 |
| Solubility: LogP | 2.163 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 49.6074 |
| nHD | 3 | BPOL | 22.9386 |
| QED | 0.7 |
| Synth | 2.536 |
| Natural Product Likeliness | 1.112 |
| NR-PPAR-gamma | 0.874 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.324 |
| Pgp-sub | 0.996 |
| HIA | 0.171 |
| CACO-2 | -4.854 |
| MDCK | 0.0000141 |
| BBB | 0.066 |
| PPB | 0.881276 |
| VDSS | 0.827 |
| FU | 0.0788164 |
| CYP1A2-inh | 0.428 |
| CYP1A2-sub | 0.301 |
| CYP2c19-inh | 0.912 |
| CYP2c19-sub | 0.092 |
| CYP2c9-inh | 0.813 |
| CYP2c9-sub | 0.96 |
| CYP2d6-inh | 0.786 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.21 |
| CYP3a4-sub | 0.364 |
| CL | 17.644 |
| T12 | 0.929 |
| hERG | 0.142 |
| Ames | 0.113 |
| ROA | 0.214 |
| SkinSen | 0.851 |
| Carcinogencity | 0.203 |
| EI | 0.647 |
| Respiratory | 0.08 |
| NR-Aromatase | 0.08 |
| Antiviral | No |
| Prediction | 0.677626 |